UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

Nature Medicine, 2019-05, Vol.25 (5), p.751-758

2019

Link zum Volltext

Verfügbarkeit prüfen

Peritoneal Dialysis Reduces the Number of Hospitalization Days in Heart Failure Patients Refractory to Diuretics

Peritoneal dialysis international, 2014-01, Vol.34 (1), p.100-108

2014

Link zum Volltext

Verfügbarkeit prüfen

A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359231156382-17588359231156382

2023

Link zum Volltext

Verfügbarkeit prüfen

Acute kidney injury in non-critical care setting: elaboration and validation of an in-hospital death prognosis score

BMC nephrology, 2019-11, Vol.20 (1), p.419-419, Article 419

2019

Link zum Volltext

Verfügbarkeit prüfen

SPRING: A Worldwide Innovative Network (WIN) Consortium phase I study of triple therapy (avelumab, axitinib, and palbociclib) in advanced non-small cell lung cancer (NSCLC) with genomic and transcriptomic correlates

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9581-9581

2020

Link zum Volltext

Verfügbarkeit prüfen

WINTHER: An international WIN Consortium precision medicine trial using genomic and transcriptomic analysis in patients with advanced malignancies

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.12011-12011

2018

Link zum Volltext

Verfügbarkeit prüfen

WINTHER: An international study to select rational therapeutics based on the analysis of matched tumor and normal biopsies in subjects with advanced malignancies

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS11625-TPS11625

2017

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Interventional Mapping System (TIMS): A novel strategy for the selection of tri-targeted therapy combinations for non-small cell lung cancer (NSCLC)

JOURNAL OF CLINICAL ONCOLOGY, 2015, Vol.33 (15_suppl), p.7524-7524

2015

Link zum Volltext

Verfügbarkeit prüfen

Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high -expressing normal lung

Therapeutic advances in medical oncology, 2022-10, Vol.14

2022

Link zum Volltext

Verfügbarkeit prüfen

Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung

Therapeutic advances in medical oncology, 2022, Vol.14, p.175883592211338-17588359221133893

2022

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients

Transplantation, 1999-01, Vol.67 (1), p.90

1999

Link zum Volltext

Verfügbarkeit prüfen

Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2‐year follow‐up

Transplant international, 2002-09, Vol.15 (8), p.387-392

2002

Link zum Volltext

Verfügbarkeit prüfen

Lymphocyte subsets and assessment of cancer risk in renal transplant recipients

Transplant international, 2002-09, Vol.15 (8), p.393-396

2002

Link zum Volltext

Verfügbarkeit prüfen

Serum immunoglobulin G levels and peritonitis in peritoneal dialysis patients

Journal of nephrology, 2015-08, Vol.28 (4), p.511-515

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study

Transplantation, 2004-04, Vol.77 (7), p.1029

2004

Link zum Volltext

Verfügbarkeit prüfen

No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients

American journal of kidney diseases, 1997-05, Vol.29 (5), p.746-753

1997

Link zum Volltext

Verfügbarkeit prüfen

Long‐term follow‐up of renal transplant recipients treated with losartan for post‐transplant erythrosis

Transplant international, 1998-07, Vol.11 (4), p.312-315

1998

Link zum Volltext

Verfügbarkeit prüfen

Use of pentoxifylline in membranous nephropathy

Lancet (British edition), 2001-05, Vol.357 (9269), p.1672-1673

2001

Link zum Volltext

Verfügbarkeit prüfen

CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients

Transplantation, 1998-05, Vol.65 (9), p.1270

1998

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipients

Nephrology, dialysis, transplantation, 1998-11, Vol.13 (11), p.2890-2893

1998

Link zum Volltext

Verfügbarkeit prüfen

Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary report

Transplantation, 1998-06, Vol.65 (11), p.1504

1998

Link zum Volltext

Verfügbarkeit prüfen

Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus

Nephrology, dialysis, transplantation, 1999-05, Vol.14 (5), p.1244-1246

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

Peritoneal Dialysis Reduces the Number of Hospitalization Days in Heart Failure Patients Refractory to Diuretics

A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology

Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival

Acute kidney injury in non-critical care setting: elaboration and validation of an in-hospital death prognosis score

SPRING: A Worldwide Innovative Network (WIN) Consortium phase I study of triple therapy (avelumab, axitinib, and palbociclib) in advanced non-small cell lung cancer (NSCLC) with genomic and transcriptomic correlates

WINTHER: An international WIN Consortium precision medicine trial using genomic and transcriptomic analysis in patients with advanced malignancies

WINTHER: An international study to select rational therapeutics based on the analysis of matched tumor and normal biopsies in subjects with advanced malignancies

Therapeutic Interventional Mapping System (TIMS): A novel strategy for the selection of tri-targeted therapy combinations for non-small cell lung cancer (NSCLC)

Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high -expressing normal lung

Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung

Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients

Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies

Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2‐year follow‐up

Lymphocyte subsets and assessment of cancer risk in renal transplant recipients

Serum immunoglobulin G levels and peritonitis in peritoneal dialysis patients

Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study

No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients

Long‐term follow‐up of renal transplant recipients treated with losartan for post‐transplant erythrosis

Use of pentoxifylline in membranous nephropathy

CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients

Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipients

Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary report

Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus

Suchergebnisse filtern